PPC

PPC
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.759B ▲ | $164.997M ▼ | $344.592M ▼ | 7.24% ▼ | $1.44 ▼ | $615.963M ▼ |
| Q2-2025 | $4.757B ▲ | $202.956M ▲ | $355.52M ▲ | 7.473% ▲ | $1.5 ▲ | $631.561M ▲ |
| Q1-2025 | $4.463B ▲ | $150.391M ▼ | $296.033M ▲ | 6.633% ▲ | $1.25 ▲ | $404.482M ▼ |
| Q4-2024 | $4.372B ▼ | $246.611M ▲ | $235.854M ▼ | 5.395% ▼ | $0.99 ▼ | $435.485M ▼ |
| Q3-2024 | $4.585B | $175.616M | $349.86M | 7.631% | $1.48 | $633.666M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $612.582M ▼ | $9.952B ▼ | $6.397B ▲ | $3.542B ▼ |
| Q2-2025 | $849.036M ▼ | $10.119B ▼ | $6.366B ▼ | $3.738B ▲ |
| Q1-2025 | $2.067B ▲ | $10.964B ▲ | $7.816B ▲ | $3.133B ▼ |
| Q4-2024 | $2.051B ▲ | $10.651B ▼ | $6.397B ▼ | $4.239B ▲ |
| Q3-2024 | $1.888B | $10.701B | $6.482B | $4.205B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $343.061M ▼ | $458.337M ▼ | $-180.632M ▼ | $-524.262M ▲ | $-242.976M ▲ | $276.474M ▼ |
| Q2-2025 | $356.009M ▲ | $495.212M ▲ | $-159.282M ▼ | $-1.585B ▼ | $-1.219B ▼ | $334.203M ▲ |
| Q1-2025 | $296.343M ▲ | $126.891M ▼ | $-97.089M ▲ | $-3.553M ▼ | $34.309M ▼ | $28.617M ▼ |
| Q4-2024 | $235.772M ▼ | $349.335M ▼ | $-153.572M ▼ | $-449K ▲ | $158.746M ▼ | $190.131M ▼ |
| Q3-2024 | $349.99M | $651.136M | $-98.529M | $-792K | $550.286M | $547.434M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Pilgrim’s Pride today looks like a scaled, vertically integrated protein producer that has moved from a more fragile profitability profile toward a stronger and more cash‑generative one, at least in the latest period. Revenue has grown steadily, and margins have recovered after a tough patch, boosting earnings and cash flow. The balance sheet now shows more cash and higher equity, which adds resilience even though leverage remains meaningful. Strategically, the company’s cost advantages, broad brand portfolio, and backing from JBS underpin a solid competitive position, while investments in automation, technology, and higher‑margin prepared foods aim to smooth out some of the volatility inherent in commodity meat markets. Key uncertainties remain around input costs, disease risk, regulation, and evolving consumer preferences, so performance is still likely to be cyclical, but the recent trajectory suggests a business that is better equipped to navigate those swings than it was a few years ago.
About Pilgrim's Pride Corporation
https://www.pilgrims.comPilgrim's Pride Corporation engages in the production, processing, marketing and distribution of fresh, frozen and value-added chicken, and pork products to retailers, distributors, and foodservice operators in the United States, the United Kingdom, Mexico, the Middle East, Asia, Continental Europe, and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.759B ▲ | $164.997M ▼ | $344.592M ▼ | 7.24% ▼ | $1.44 ▼ | $615.963M ▼ |
| Q2-2025 | $4.757B ▲ | $202.956M ▲ | $355.52M ▲ | 7.473% ▲ | $1.5 ▲ | $631.561M ▲ |
| Q1-2025 | $4.463B ▲ | $150.391M ▼ | $296.033M ▲ | 6.633% ▲ | $1.25 ▲ | $404.482M ▼ |
| Q4-2024 | $4.372B ▼ | $246.611M ▲ | $235.854M ▼ | 5.395% ▼ | $0.99 ▼ | $435.485M ▼ |
| Q3-2024 | $4.585B | $175.616M | $349.86M | 7.631% | $1.48 | $633.666M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $612.582M ▼ | $9.952B ▼ | $6.397B ▲ | $3.542B ▼ |
| Q2-2025 | $849.036M ▼ | $10.119B ▼ | $6.366B ▼ | $3.738B ▲ |
| Q1-2025 | $2.067B ▲ | $10.964B ▲ | $7.816B ▲ | $3.133B ▼ |
| Q4-2024 | $2.051B ▲ | $10.651B ▼ | $6.397B ▼ | $4.239B ▲ |
| Q3-2024 | $1.888B | $10.701B | $6.482B | $4.205B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $343.061M ▼ | $458.337M ▼ | $-180.632M ▼ | $-524.262M ▲ | $-242.976M ▲ | $276.474M ▼ |
| Q2-2025 | $356.009M ▲ | $495.212M ▲ | $-159.282M ▼ | $-1.585B ▼ | $-1.219B ▼ | $334.203M ▲ |
| Q1-2025 | $296.343M ▲ | $126.891M ▼ | $-97.089M ▲ | $-3.553M ▼ | $34.309M ▼ | $28.617M ▼ |
| Q4-2024 | $235.772M ▼ | $349.335M ▼ | $-153.572M ▼ | $-449K ▲ | $158.746M ▼ | $190.131M ▼ |
| Q3-2024 | $349.99M | $651.136M | $-98.529M | $-792K | $550.286M | $547.434M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Pilgrim’s Pride today looks like a scaled, vertically integrated protein producer that has moved from a more fragile profitability profile toward a stronger and more cash‑generative one, at least in the latest period. Revenue has grown steadily, and margins have recovered after a tough patch, boosting earnings and cash flow. The balance sheet now shows more cash and higher equity, which adds resilience even though leverage remains meaningful. Strategically, the company’s cost advantages, broad brand portfolio, and backing from JBS underpin a solid competitive position, while investments in automation, technology, and higher‑margin prepared foods aim to smooth out some of the volatility inherent in commodity meat markets. Key uncertainties remain around input costs, disease risk, regulation, and evolving consumer preferences, so performance is still likely to be cyclical, but the recent trajectory suggests a business that is better equipped to navigate those swings than it was a few years ago.

CEO
Fabio Sandri
Compensation Summary
(Year 2024)

CEO
Fabio Sandri
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1999-08-02 | Forward | 3:2 |
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
5.673M Shares
$215.791M

BLACKROCK, INC.
5.169M Shares
$196.624M

AQR CAPITAL MANAGEMENT LLC
4.482M Shares
$170.5M

BLACKROCK INC.
4.223M Shares
$160.635M

DIMENSIONAL FUND ADVISORS LP
2.676M Shares
$101.802M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
2.239M Shares
$85.167M

D. E. SHAW & CO., INC.
1.884M Shares
$71.653M

BANK OF AMERICA CORP /DE/
1.553M Shares
$59.059M

STATE STREET CORP
1.552M Shares
$59.052M

JACOBS LEVY EQUITY MANAGEMENT, INC
1.535M Shares
$58.393M

INVESCO LTD.
1.459M Shares
$55.512M

RENAISSANCE TECHNOLOGIES LLC
1.426M Shares
$54.234M

MORGAN STANLEY
1.352M Shares
$51.445M

RUSSELL FRANK CO/
1.306M Shares
$49.664M

ASSETMARK, INC
1.129M Shares
$42.938M

GOLDMAN SACHS GROUP INC
1.061M Shares
$40.372M

GEODE CAPITAL MANAGEMENT, LLC
983.006K Shares
$37.394M

QUBE RESEARCH & TECHNOLOGIES LTD
958.312K Shares
$36.454M

NUMERIC INVESTORS LLC
878.8K Shares
$33.43M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
707.23K Shares
$26.903M
Summary
Only Showing The Top 20



